Soleno Therapeutics (SLNO) Net Cash Flow (2013 - 2026)
Soleno Therapeutics (SLNO) reported Net Cash Flow of $62.9 million for Q1 2026, up 1053.77% year-over-year from $5.5 million in Q1 2025, and up 135.64% on a QoQ basis from -$176.6 million in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of Net Cash Flow data on file, last reported at $62.9 million in Q1 2026.
- Quarterly Net Cash Flow rose 1053.77% year-over-year to $62.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.7 million (up 34.33% YoY) and the FY2025 annual result came in at -$17.8 million, up 78.2% from the prior year.
- Net Cash Flow improved to $62.9 million in Q1 2026 per SLNO's latest filing, from -$176.6 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $170.2 million in Q3 2025 and bottomed at -$176.6 million in Q4 2025.
- The 5-year median for Net Cash Flow is -$4.3 million (2022), against an average of $6.6 million.
- The widest annual swing landed in 2023, when Net Cash Flow surged 2377.02%; it then slumped 1785.17% in 2024.
- Tracing SLNO's Net Cash Flow over 5 years: stood at -$5.1 million in 2022, then surged by 2377.02% to $117.2 million in 2023, then tumbled by 66.3% to $39.5 million in 2024, then sank by 546.81% to -$176.6 million in 2025, then surged by 135.64% to $62.9 million in 2026.
- Per Business Quant, the three latest SLNO Net Cash Flow figures stand at $62.9 million (Q1 2026), -$176.6 million (Q4 2025), and $170.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 62.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.92 Mn |
| Mar 31, 2026 | 62.92 Mn |
| Dec 31, 2025 | -176.56 Mn |
| Dec 31, 2025 | -176.56 Mn |
| Sep 30, 2025 | 170.21 Mn |
| Sep 30, 2025 | 170.21 Mn |
| Jun 30, 2025 | -4.87 Mn |
| Jun 30, 2025 | -4.87 Mn |
| Mar 31, 2025 | -6.60 Mn |
| Mar 31, 2025 | -6.60 Mn |
| Dec 31, 2024 | 39.52 Mn |
| Dec 31, 2024 | 39.52 Mn |
| Sep 30, 2024 | -8.61 Mn |
| Sep 30, 2024 | -8.61 Mn |
| Jun 30, 2024 | 14.18 Mn |
| Jun 30, 2024 | 14.18 Mn |
| Mar 31, 2024 | -126.83 Mn |
| Mar 31, 2024 | -126.83 Mn |
| Dec 31, 2023 | 117.24 Mn |
| Dec 31, 2023 | 117.24 Mn |
| Sep 30, 2023 | 33.07 Mn |
| Sep 30, 2023 | 33.07 Mn |
| Jun 30, 2023 | 11.49 Mn |
| Jun 30, 2023 | 11.49 Mn |
| Mar 31, 2023 | -6.73 Mn |
| Mar 31, 2023 | -6.73 Mn |
| Dec 31, 2022 | -5.15 Mn |
| Dec 31, 2022 | -5.15 Mn |
| Sep 30, 2022 | -4.31 Mn |
| Sep 30, 2022 | -4.31 Mn |
| Jun 30, 2022 | -4.90 Mn |
| Jun 30, 2022 | -4.90 Mn |
| Mar 31, 2022 | 7.67 Mn |
| Mar 31, 2022 | 7.67 Mn |
| Dec 31, 2021 | -6.88 Mn |
| Dec 31, 2021 | -6.88 Mn |
| Sep 30, 2021 | -5.41 Mn |
| Sep 30, 2021 | -5.41 Mn |
| Jun 30, 2021 | -8.01 Mn |
| Jun 30, 2021 | -8.01 Mn |
| Mar 31, 2021 | -7.62 Mn |
| Mar 31, 2021 | -7.62 Mn |
| Dec 31, 2020 | -6.91 Mn |
| Dec 31, 2020 | -6.91 Mn |
| Sep 30, 2020 | -6.36 Mn |
| Sep 30, 2020 | -6.36 Mn |
| Jun 30, 2020 | 47.43 Mn |
| Jun 30, 2020 | 47.43 Mn |
| Mar 31, 2020 | -5.66 Mn |
| Mar 31, 2020 | -5.66 Mn |
| Dec 31, 2019 | -4.97 Mn |
| Dec 31, 2019 | -4.97 Mn |
| Sep 30, 2019 | -4.28 Mn |
| Sep 30, 2019 | -4.28 Mn |
| Jun 30, 2019 | -3.90 Mn |
| Jun 30, 2019 | -3.90 Mn |
| Mar 31, 2019 | -3.70 Mn |
| Mar 31, 2019 | -3.70 Mn |
| Dec 31, 2018 | 12.39 Mn |
| Dec 31, 2018 | 12.39 Mn |
| Sep 30, 2018 | -1.98 Mn |
| Sep 30, 2018 | -1.98 Mn |
| Jun 30, 2018 | -1.81 Mn |
| Jun 30, 2018 | -1.81 Mn |
| Mar 31, 2018 | -2.63 Mn |
| Mar 31, 2018 | -2.63 Mn |
| Dec 31, 2017 | 14.48 Mn |
| Dec 31, 2017 | 14.48 Mn |
| Sep 30, 2017 | -3.64 Mn |
| Sep 30, 2017 | -3.64 Mn |
| Jun 30, 2017 | -1.26 Mn |
| Jun 30, 2017 | -1.26 Mn |
| Mar 31, 2017 | 7.81 Mn |
| Mar 31, 2017 | 7.81 Mn |
| Dec 31, 2016 | -1.32 Mn |
| Dec 31, 2016 | -1.32 Mn |
| Sep 30, 2016 | 7.78 Mn |
| Sep 30, 2016 | 7.78 Mn |
| Jun 30, 2016 | -3.99 Mn |
| Jun 30, 2016 | -3.99 Mn |
| Mar 31, 2016 | 997,000.00 |
| Mar 31, 2016 | 997,000.00 |
| Dec 31, 2015 | 774,813.00 |
| Dec 31, 2015 | 774,813.00 |
| Sep 30, 2015 | -2.81 Mn |
| Sep 30, 2015 | -2.81 Mn |
| Jun 30, 2015 | -2.00 Mn |
| Jun 30, 2015 | -2.00 Mn |
| Mar 31, 2015 | 1.57 Mn |
| Mar 31, 2015 | 1.57 Mn |
| Dec 31, 2014 | 7.92 Mn |
| Dec 31, 2014 | 7.92 Mn |
| Sep 30, 2014 | -1.14 Mn |
| Sep 30, 2014 | -1.14 Mn |
| Jun 30, 2014 | -1.16 Mn |
| Jun 30, 2014 | -1.16 Mn |
| Mar 31, 2014 | -505,000.00 |
| Mar 31, 2014 | -505,000.00 |
| Dec 31, 2013 | -722,492.00 |
| Dec 31, 2013 | -722,492.00 |